Zoetis is trading 4.07% up now at $77.31 as healthcare stocks rally.
- Healthcare gains reflect improving earnings expectations, attractive valuations, increased dealmaking and defensive growth; investors rotate away from technology.
- Technology shares lag amid elevated Treasury yields. No clear company-specific announcement explains the August 19, 2026 move.
- The Polen Capital filing is not a direct catalyst; recent earnings-related guidance concerns predate this session. Confidence is medium: the sector explanation aligns, but company-specific coverage is limited.